9), the prognostic value of brain SUV mean was confirmed for patients who received chemotherapy (86%), radiotherapy (65%), and immunotherapy (58%), but did not reach statistical significance in patients treated with targeted therapies (32%, P = 0.16).
← all excerpts
Brain Metabolic Activity Measured by [<sup>18</sup>F]FDG PET/CT Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer.
1
0.1600
0.1600